Investigating the association between ALK Receptor Tyrosine Kinase inhibitors and pulmonary arterial hypertension: a disproportionality analysis from the WHO pharmacovigilance database - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Respiratory Journal Année : 2021

Investigating the association between ALK Receptor Tyrosine Kinase inhibitors and pulmonary arterial hypertension: a disproportionality analysis from the WHO pharmacovigilance database

Dates et versions

hal-03434176 , version 1 (18-11-2021)

Identifiants

Citer

Charles Khouri, Alex Hlavaty, Matthieu Roustit, Jean-Luc Cracowski, Marie-Camille Chaumais, et al.. Investigating the association between ALK Receptor Tyrosine Kinase inhibitors and pulmonary arterial hypertension: a disproportionality analysis from the WHO pharmacovigilance database. European Respiratory Journal, 2021, pp.2101576. ⟨10.1183/13993003.01576-2021⟩. ⟨hal-03434176⟩
18 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More